Archivos de la Sociedad Espanola de Oftalmologia · 2007
[Persistent corneal defects treated with botulinum toxin-induced ptosis].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Vleming E N, Pérez-Rico C, Montes M A, Pareja J
Аннотация
OBJECTIVES: To evaluate the use of botulinum toxin (BTX) induced ptosis in the treatment of corneal pathology.
METHODS: We employed two BTX injections into the superior lid of 10 eyes (9 patients). We evaluated the degree of ptosis, its duration and the effect on the corneal lesion.
RESULTS: Complete ptosis resulted in seven eyes and the corneal pathology resolved in all of them. There were no relevant complications.
CONCLUSIONS: BTX treatment is a simple and safe technique for treating refractory corneal pathology. It has significant advantages over surgical tarsorrhaphy and is especially useful where the pathology does not require surgery.
METHODS: We employed two BTX injections into the superior lid of 10 eyes (9 patients). We evaluated the degree of ptosis, its duration and the effect on the corneal lesion.
RESULTS: Complete ptosis resulted in seven eyes and the corneal pathology resolved in all of them. There were no relevant complications.
CONCLUSIONS: BTX treatment is a simple and safe technique for treating refractory corneal pathology. It has significant advantages over surgical tarsorrhaphy and is especially useful where the pathology does not require surgery.